rethinkPeptides Search
Menu
Study breakdown

Melittin: Bee Venom Peptide Shows Broad Anti-Viral Activity Against Multiple Viruses

ReviewLow Moderate evidence
The takeaway

Melittin, the main peptide in honeybee venom, has demonstrated antiviral activity against at least nine different viruses including HIV, influenza, and herpes simplex virus.

9+ viruses inhibited

Melittin demonstrated antiviral activity across diverse viral families including HIV, influenza A, and HSV

What the researchers found

Melittin demonstrates antiviral activity against at least nine different viruses spanning multiple families, suggesting broad-spectrum potential as a venom-derived antiviral peptide.

Why it matters

Viral infections remain a leading cause of death globally, and drug resistance is growing. Natural venom peptides like melittin could offer new antiviral mechanisms that complement existing treatments.

The numbers in context

Active against 9+ viruses; properties: anti-cancer, anti-inflammatory, anti-diabetic, adjuvant; safety challenges significant

How the study worked

Narrative review synthesizing experimental studies on melittin antiviral activity conducted over several decades.

Who was studied

Review of melittin antiviral studies against coxsackievirus, enterovirus, influenza A, HIV, HSV, Junin, RSV, VSV, TMV

What this study cannot tell us

Most evidence is from in-vitro studies; melittin is cytotoxic at higher concentrations; safety profile for therapeutic use is unclear; molecular mechanisms remain poorly characterized.

How to read the evidence

Broad observational evidence across many in-vitro studies, but lacks clinical trials or robust in-vivo data; safety profile is a major gap.

When this study was published

Published in 2020; interest in venom-derived antivirals has grown since the COVID-19 pandemic highlighted the need for broad-spectrum antiviral agents.

The bigger picture

Melittin exemplifies how animal venom peptides — evolved for defense — may be repurposed as broad-spectrum antimicrobial and antiviral therapeutics, expanding the natural product drug pipeline.

Questions still open

  • Can melittin be modified to retain antiviral activity while reducing its cytotoxicity?
  • What are the specific molecular mechanisms behind melittin broad-spectrum antiviral action?
  • Could nanoformulation delivery systems make melittin safe enough for clinical antiviral use?

Common questions

Can bee venom kill viruses?
Melittin, the main peptide in bee venom, has shown ability to inhibit at least nine different viruses in laboratory studies, though it has not yet been tested as a clinical antiviral drug.
Is melittin safe to use as medicine?
Melittin is cytotoxic at higher doses, which is a major challenge. Researchers are exploring modified versions and nanodelivery systems to make it safe for therapeutic use.

Read the original research

Melittin: a venom-derived peptide with promising anti-viral properties.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 39(1), 5-17

Citation

Memariani, Hamed; Memariani, Mojtaba; Moravvej, Hamideh; Shahidi-Dadras, Mohammad. (2020). Melittin: a venom-derived peptide with promising anti-viral properties.. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 39(1), 5-17. https://doi.org/10.1007/s10096-019-03674-0